CHEMCLIN DIAGNOSTICSCHEMCLIN DIAGNOSTICSCHEMCLIN DIAGNOSTICS

CHEMCLIN DIAGNOSTICS

No trades
See on Supercharts

688468 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Chemclin Diagnostics Co., Ltd. engages in the research, development, production, and sales of clinical immuno chemiluminescence diagnostic testing reagents and instruments. Its products are LiCA series of diagnostic reagents based on photoexcitation chemiluminescence, and CC series diagnostic reagents and instruments based on enzymatic chemiluminescence. The company's products are used in the detection of infectious diseases such as hepatitis B, C, AIDS, syphilis, hepatitis A, and hepatitis E markers, tumor markers, thyroid hormones, reproductive endocrine hormones, and myocardial markers and inflammation. Chemclin Diagnostics was founded on May 10, 2007and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688468 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company